Abstract
China' s demand for Hepatitis Treatment Drugs has grown at a fast pace in the
past decade. In the next five years, both production and demand will continue
to grow. This new study examines China' s economic trends, investment
environment, industry development, supply and demand, industry capacity,
industry structure, marketing channels and major industry participants.
Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013
and 2018 are presented. Major producers in China are profiled.
Table of Contents
I. INTRODUCTION
- Report Scope and Methodology
- Executive Summary
II. BUSINESS ENVIRONMENT
- Economic Outlook
- Key Economic Indicators
- Industrial Output
- Population and Labor
- Foreign Investment
- Foreign Trade
- Financial and Tax Regulations
- Banking System and Regulations
- Foreign Exchange
- Taxes, Tariff and Custom Duties
III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS
- Hepatitis Drugs Industry Structure
- Market Size
- Market Growth Drivers
- Hepatitis Drugs Industry Sales Volumes
- Major Producer Facility Locations and Sales Volumes
- Market Share of Key Producers
- Labor Cost
- Potential Entrants
- Major Distributors
- Major Foreign Investment
- Technology Development
IV. HEPATITIS DRUGS PRODUCTION AND DEMAND
- Overview
- Sales Volumes of Hepatitis Drugs by Region in 2008
- Hepatitis Drugs Sales Volumes
- Liver Protection Drugs
- Nucleoside Drugs
- Interferon (IFN)
- Other Hepatitis Drugs
- Hepatitis Drugs Imports and Exports
- Hepatitis Drugs Imports
- Hepatitis Drugs Exports
- Pricing Trend
V. HEPATITIS DRUGS MARKET OUTLOOK
- Hepatitis Drugs Market Outlook Overview
- Government Regulation
- Health Care Insurance Industry Overview
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Physicians and Physician Visits
VI. MARKETING STRATEGIES
- China Market Entry Overview
- China' s Distribution System
- Hepatitis Drugs Distribution Channels
- Transportation and Freight Infrastructure
- Communications
- China' s Market Entry
- Export to China
- Indirect export
- Direct Export
- License and Contract Manufacture
- Assembling in China
- Contract Manufacturing
- Trade Permit
- Investment
- Equity Joint Venture
- Contractual Joint Venture
- Wholly Foreign-Owned Enterprise
VII. HEPATITIS DRUGS PRODUCER DIRECTORY
- Hepatitis Drugs Producer Profiles
LIST OF TABLES
I. INTRODUCTION
II. BUSINESS ENVIRONMENT
- Key Economic Indicators
- Industrial Output
- Population and Labor Force Trends
- Foreign Investment and Loans
- Foreign Trade
III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS
- Hepatitis Drugs Industry Sales Volumes
- Major Producer Facility Locations
- Major Hepatitis Drugs Producer Sales Volumes
- Market Share of Key Producers
- Major Foreign Investments in China
IV. HEPATITIS DRUGS PRODUCTION AND DEMAND
- Hepatitis Drugs Sales Volumes
- Sales Volumes of Hepatitis Drugs by Region in 2008
- Major Liver Protection Drugs Producer Sales Volumes
- Liver Protection Drugs Sales Volumes
- Major Nucleoside Drugs Producer Sales Volumes
- Nucleoside Drugs Sales Volumes
- Major IFN Drugs Producer Sales Volumes
- Interferon (IFN) Sales Volumes
- Other Hepatitis Drugs Sales Volumes
- China Hepatitis Drugs Imports and Exports
V. HEPATITIS DRUGS MARKET OUTLOOK
- Total hepatitis Drugs Sales Volumes by Market
- Hepatitis Drugs Sales Volumes and Market Share in 2008
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION
- China' s Hepatitis Drugs Sales Volumes
II. BUSINESS ENVIRONMENT
- China' s GDP and Growth Rate
- Industrial Output by Ownership
- China' s Imports and Exports
III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS
- Hepatitis Drugs Sales Volumes in China
IV. HEPATITIS DRUGS PRODUCTION AND DEMAND
- Total Hepatitis Drugs Sales Volumes
- Total Hepatitis Drugs Imports and Exports
V. HEPATITIS DRUGS MARKET OUTLOOK
- Hepatitis Drugs Sales Volumes by Market in 2008
VI. MARKETING STRATEGIES
- China' s Distribution Channel
| 
